TREATMENT OF CANCER USING AN ANTI-HLA-G/ANTI-CD3 BISPECIFIC ANTIBODY AND A 4-1BB (CD137) AGONIST
Application
US20260092118A1
Kind: A1
Apr 02, 2026
Assignee
Hoffmann-La Roche Inc.
Inventors
Meher MAJETY, Carina HAGE, Johannes SAM
Abstract
The present invention relates to the treatment of cancer, in particular to the treatment of cancer using an anti-HLA-G/anti-CD3 bispecific antibody and a 4-1BB (CD137) agonist.
CPC Classifications
C07K 16/2833
A61P 35/00
C07K 14/4705
C07K 16/2809
C07K 16/40
A61K 38/00
A61K 2039/505
C07K 2317/31
C07K 2317/33
C07K 2317/522
C07K 2317/55
C07K 2317/565
C07K 2317/71
C07K 2319/00
Filing Date
2025-09-10
Application No.
19325175